Infusions, SubcutaneousInsulin, Long-ActingInsulin Infusion SystemsInsulin, IsophaneHypoglycemic AgentsInsulinInjections, SubcutaneousInsulin LisproDiabetes Mellitus, Type 1HypoglycemiaBlood GlucoseHemoglobin A, GlycosylatedInsulin AspartDiabetes Mellitus, Type 2Infusion Pumps, ImplantableVenomsPancreas, ArtificialBlood Glucose Self-MonitoringDiabetic KetoacidosisInsulin, Regular, HumanDiabetes Mellitus, LipoatrophicInsulin, Short-ActingInsulinsReceptor, InsulinSulfonylurea CompoundsMythologyInfusions, ParenteralHyperglycemiaMetforminDrug Administration ScheduleDiabetes MellitusMonitoring, AmbulatoryPostprandial PeriodInfusion PumpsCross-Over StudiesTreatment OutcomePatient Medication KnowledgeInsulin ResistanceC-PeptideDrug SubstitutionDrug Therapy, CombinationFastingRandomized Controlled Trials as TopicModels, EconomicPatient SatisfactionInsulin AntibodiesInsulin Receptor Substrate ProteinsTime FactorsGlucoseSafetyDiabetes ComplicationsDose-Response Relationship, DrugGlucose Clamp TechniqueQuality-Adjusted Life YearsDiabetes Mellitus, ExperimentalInfusions, IntravenousInjectionsClinical Trials, Phase III as TopicBody WeightInsulin AntagonistsPeptidesCircadian RhythmAlgorithmsNational Health ProgramsMulticenter Studies as TopicDelayed-Action PreparationsIslets of LangerhansThiazolidinedionesGlucose Tolerance TestAdministration, OralNeoplasmsDouble-Blind MethodDrug CostsProbabilityBody Mass IndexRetrospective StudiesInsulin, Regular, PorkDatabases, FactualHyperinsulinismAdipose TissueInsulin-Secreting CellsCost-Benefit AnalysisJapanMaternal-Fetal ExchangeGlucagonObesityReference ValuesIncidenceProinsulinProspective StudiesFranceAsian Continental Ancestry GroupChronotherapyGlucagon-Like Peptide 1Receptor, IGF Type 1LiverMuscle, SkeletalIsoindolesSignal TransductionFatty Acids, Nonesterified